Market Summary - April 10, 2026
US Market Overview
The final session of a turbulent week on Wall Street begins with a sense of calm and cautious optimism. Major US indices have recovered approximately 9% since the local low on March 31, returning to levels seen before the onset of the war in Iran, despite ongoing geopolitical tensions. Futures contracts on the main indices are stabilizing around opening levels, with gains limited to about 0.2%.
Macroeconomic Data
The Bureau of Labor Statistics (BLS) released the US inflation data for March, which showed a noticeable acceleration in price growth, attributed to the Iran conflict. However, the inflation reading came in slightly below market consensus:
- CPI inflation (YoY): 3.3% (expected: 3.4%; previous: 2.4%)
- Core CPI inflation (YoY): 2.6% (expected: 2.7%; previous: 2.5%)
Market Analysis
The US100 index chart indicates a strong return of buyer control after rebounding from the 23,000-point level. The EMA moving averages are showing bullish momentum, and the MACD is signaling a bullish trend. The base-case scenario suggests a potential test of the 26,000 points, although bulls should be cautious of a rising RSI.
Company News
- CoreWeave (CRWV.US): Announced a partnership with Anthropic, leading to a 3% increase in shares.
- Lumentum Holdings (LITE.US): CEO reported strong demand driven by AI, with shares up over 2%.
- Nike (NKE.US): Received a negative recommendation from an investment firm, resulting in a 1% decline in shares.
- Palantir (PLTR.US): Experienced a significant decline due to competition concerns from Anthropic’s solutions.
- Organon (OGN.US): Shares surged over 20% following reports of a potential acquisition by Sun Pharmaceutical for $12 billion.
- CrowdStrike (CRWD.US) and Palo Alto (PANW.US): Both companies are facing declines amid concerns regarding Anthropic’s new AI model.